Metropolitan Life Insurance Co NY Decreases Stock Position in CME Group Inc. (NASDAQ:CME)

Metropolitan Life Insurance Co NY cut its stake in CME Group Inc. (NASDAQ:CME) by 2.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,676 shares of the financial services provider’s stock after selling 413 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in CME Group were worth $2,905,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. MayTech Global Investments LLC purchased a new position in shares of CME Group during the 4th quarter worth about $25,000. Power Corp of Canada purchased a new position in shares of CME Group during the first quarter valued at approximately $26,000. Silicon Valley Capital Partners bought a new position in shares of CME Group during the first quarter valued at approximately $27,000. Cascade Investment Advisors Inc. bought a new position in shares of CME Group during the first quarter valued at approximately $27,000. Finally, Grayhawk Investment Strategies Inc. purchased a new stake in shares of CME Group in the first quarter worth approximately $28,000. 85.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CME. Morgan Stanley boosted their price objective on CME Group from $215.00 to $220.00 and gave the company an “equal weight” rating in a report on Thursday, October 26th. Barclays cut their price target on shares of CME Group from $247.00 to $244.00 and set an “overweight” rating on the stock in a report on Thursday, October 26th. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $190.00 to $197.00 and gave the company a “neutral” rating in a report on Wednesday, October 11th. StockNews.com assumed coverage on shares of CME Group in a research note on Thursday, October 5th. They issued a “hold” rating on the stock. Finally, Citigroup lifted their price target on shares of CME Group from $215.00 to $240.00 and gave the company a “buy” rating in a research note on Thursday, October 12th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $220.00.

CME Group Trading Down 0.7 %

Shares of NASDAQ:CME opened at $212.00 on Tuesday. The company has a market capitalization of $76.32 billion, a PE ratio of 25.30, a P/E/G ratio of 2.30 and a beta of 0.44. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $166.54 and a 12-month high of $221.76. The business’s fifty day simple moving average is $210.34 and its 200-day simple moving average is $197.47.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 25th. The financial services provider reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.04. CME Group had a net margin of 57.03% and a return on equity of 11.70%. The business had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.34 billion. As a group, equities research analysts predict that CME Group Inc. will post 9.15 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 28th. Shareholders of record on Friday, December 8th will be paid a $1.10 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $4.40 annualized dividend and a yield of 2.08%. CME Group’s dividend payout ratio (DPR) is 52.51%.

Insiders Place Their Bets

In related news, Director Dennis Suskind sold 1,500 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $213.60, for a total transaction of $320,400.00. Following the transaction, the director now directly owns 3,167 shares in the company, valued at approximately $676,471.20. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other CME Group news, insider Timothy Francis Mccourt sold 1,043 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $216.37, for a total transaction of $225,673.91. Following the transaction, the insider now owns 6,352 shares in the company, valued at approximately $1,374,382.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Dennis Suskind sold 1,500 shares of CME Group stock in a transaction on Monday, November 6th. The stock was sold at an average price of $213.60, for a total transaction of $320,400.00. Following the sale, the director now owns 3,167 shares of the company’s stock, valued at $676,471.20. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,386 shares of company stock valued at $725,855. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.